PA
POET icon

PharVision Advisers’s POET Technologies POET Stock Holding History

PharVision Advisers’s Portfolio POET Stock Details POET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-69,072
Closed -$437K – 512
2025
Q4 		$437K Buy
+69,072
New +$438K 0.22% 87

Other funds holding POET

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $17B AUM 39.66% 1-Year Est. Return
PCMC
Paragon Capital Management (Colorado) Denver, Colorado $528M AUM 24.61% 1-Year Est. Return

PharVision Advisers's POET Position: Q1 2026 in Review

PharVision Advisers sold out of POET Technologies (POET) in Q1 2026, closing a stake of 69,072 shares — an estimated $437K sold.

PharVision Advisers first reported a position in POET in Q4 2025 and held it in 1 quarter. The position peaked at $437K in Q4 2025. 107 funds tracked by Wall St. Rank hold POET as of Q1 2026.

  • PharVision Advisers reported no remaining POET Technologies position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 69,072 POET Technologies shares in Q1 2026, an estimated $437K.
  • PharVision Advisers first reported a position in POET Technologies in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's POET Technologies position peaked at $437K in Q4 2025.
  • 107 funds tracked by Wall St. Rank held POET Technologies as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.